Subgroups of the BENEFIT study: risk of developing MS and treatment effect of interferon beta-1b

C.H. Polman, L. Kappos, M.S. Freedman, G. Edan, H.P. Hartung, D. H. Miller, X. Montalban, F. Barkhof, K. Selmaj, B.M.J. Uitdehaag, S. Dahms, L. Bauer, C. Pohl, R. Sandbrink

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)480-487
JournalJournal of Neurology
Volume255
Issue number4
DOIs
Publication statusPublished - 2008

Cite this

Polman, C. H., Kappos, L., Freedman, M. S., Edan, G., Hartung, H. P., Miller, D. H., ... Sandbrink, R. (2008). Subgroups of the BENEFIT study: risk of developing MS and treatment effect of interferon beta-1b. Journal of Neurology, 255(4), 480-487. https://doi.org/10.1007/s00415-007-0733-2
Polman, C.H. ; Kappos, L. ; Freedman, M.S. ; Edan, G. ; Hartung, H.P. ; Miller, D. H. ; Montalban, X. ; Barkhof, F. ; Selmaj, K. ; Uitdehaag, B.M.J. ; Dahms, S. ; Bauer, L. ; Pohl, C. ; Sandbrink, R. / Subgroups of the BENEFIT study: risk of developing MS and treatment effect of interferon beta-1b. In: Journal of Neurology. 2008 ; Vol. 255, No. 4. pp. 480-487.
@article{d442bca343ec4bcfa0cb4ea5bb092c0e,
title = "Subgroups of the BENEFIT study: risk of developing MS and treatment effect of interferon beta-1b",
author = "C.H. Polman and L. Kappos and M.S. Freedman and G. Edan and H.P. Hartung and Miller, {D. H.} and X. Montalban and F. Barkhof and K. Selmaj and B.M.J. Uitdehaag and S. Dahms and L. Bauer and C. Pohl and R. Sandbrink",
year = "2008",
doi = "10.1007/s00415-007-0733-2",
language = "Undefined/Unknown",
volume = "255",
pages = "480--487",
journal = "Journal of Neurology",
issn = "0340-5354",
publisher = "D. Steinkopff-Verlag",
number = "4",

}

Polman, CH, Kappos, L, Freedman, MS, Edan, G, Hartung, HP, Miller, DH, Montalban, X, Barkhof, F, Selmaj, K, Uitdehaag, BMJ, Dahms, S, Bauer, L, Pohl, C & Sandbrink, R 2008, 'Subgroups of the BENEFIT study: risk of developing MS and treatment effect of interferon beta-1b' Journal of Neurology, vol. 255, no. 4, pp. 480-487. https://doi.org/10.1007/s00415-007-0733-2

Subgroups of the BENEFIT study: risk of developing MS and treatment effect of interferon beta-1b. / Polman, C.H.; Kappos, L.; Freedman, M.S.; Edan, G.; Hartung, H.P.; Miller, D. H.; Montalban, X.; Barkhof, F.; Selmaj, K.; Uitdehaag, B.M.J.; Dahms, S.; Bauer, L.; Pohl, C.; Sandbrink, R.

In: Journal of Neurology, Vol. 255, No. 4, 2008, p. 480-487.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - Subgroups of the BENEFIT study: risk of developing MS and treatment effect of interferon beta-1b

AU - Polman, C.H.

AU - Kappos, L.

AU - Freedman, M.S.

AU - Edan, G.

AU - Hartung, H.P.

AU - Miller, D. H.

AU - Montalban, X.

AU - Barkhof, F.

AU - Selmaj, K.

AU - Uitdehaag, B.M.J.

AU - Dahms, S.

AU - Bauer, L.

AU - Pohl, C.

AU - Sandbrink, R.

PY - 2008

Y1 - 2008

U2 - 10.1007/s00415-007-0733-2

DO - 10.1007/s00415-007-0733-2

M3 - Article

VL - 255

SP - 480

EP - 487

JO - Journal of Neurology

JF - Journal of Neurology

SN - 0340-5354

IS - 4

ER -